Repetitive profound thrombocytopenia after treatment with tirofiban : a case report . The P08514 /IIIa inhibitors are used in the acute coronary syndromes and interventional cardiology as antiplatelet agents . These drugs induce thrombocytopenia in approximately 1-5 % of patients . Thrombocytopenia is rapid in onset and antibody mediated . DB00054 is associated with higher incidence of thrombocytopenia than eptifibatide and tirofiban . Profound thrombocytopenia has reportedly been an issue with abciximab , but not with tirofiban . We reported a case of acute profound thrombocytopenia due to on tirofiban treatment in the same patient at two different times .